Clinical Trial Update: Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt

View source ↗

Summary

A completed clinical trial evaluated the safety and effectiveness of the generic fingolimod brand Sphingomod in patients with relapsing-remitting multiple scler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Sphingomod (fingolimod)

Snippet

Sponsor: Hikma Pharmaceuticals LLC | Conditions: Relapsing-Remitting Multiple Sclerosis | Status: COMPLETED